Genscript Biotech Corporation (FRA:G51)
1.516
+0.044 (3.02%)
Last updated: Jan 8, 2026, 8:06 AM CET
31.83% (1Y)
| Market Cap | 3.46B |
| Revenue (ttm) | 705.13M |
| Net Income (ttm) | 2.65B |
| Shares Out | n/a |
| EPS (ttm) | 1.20 |
| PE Ratio | 1.30 |
| Forward PE | 37.56 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 45 |
| Open | 1.516 |
| Previous Close | 1.472 |
| Day's Range | 1.516 - 1.516 |
| 52-Week Range | 1.100 - 2.042 |
| Beta | n/a |
| RSI | 54.53 |
| Earnings Date | Mar 10, 2026 |